| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 765 | 63 | 6,037 | 3,105 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 765 | 63 | 6,037 | 3,105 | | | Operating Expenses | | Research Development | 2,296 | 2,281 | 2,916 | 3,550 | | Selling General and Administrative | 2,566 | 2,030 | 2,095 | 1,858 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,097) | (4,248) | 1,026 | (2,303) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 37 | 66 | 99 | 146 | | Earnings Before Interest And Taxes | (4,060) | (4,181) | 1,125 | (2,156) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (4,060) | (4,181) | 1,125 | (2,156) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,060) | (4,181) | 1,125 | (2,156) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,060) | (4,181) | 1,125 | (2,156) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,060) | ($4,181) | $1,125 | ($2,156) |
|
0.16% Nasdaq 
0.05%
Income Statement
